A Snapshot of Boston Scientific's Business And Outlook

Boston Scientific (NYSE:BSX) generates its revenues from Cardiovascular, Rhythm Management, and MedSurg businesses. The Cardiovascular segment currently accounts for around 40% of the total revenues, while the other two segments account for 30% each. We believe that the MedSurg segment will grow...